文献速递肝病

基因型与严重胆汁酸盐输出泵缺陷自然史相关

Genotype correlates with the natural history of severe bile salt export pump deficiency.
PubMed 文献 · J Hepatol · 2020-02-20

这项多中心回顾性队列研究纳入264例ABCB11双等位基因致病突变的严重BSEP缺陷患者,按基因型严重程度分为BSEP1、BSEP2、BSEP3三组。基因型严重程度与自体肝生存期、肝细胞癌风险及手术胆汁分流后生存获益显著相关,术后血清胆汁酸参数可预测长期自体肝生存。

要点

  • 基因型严重程度可预测严重BSEP缺陷患者的长期自体肝生存。
  • BSEP3组15岁时肝细胞癌比例达34%,显著高于BSEP1和BSEP2组。
  • 术后血清胆汁酸<102 μmol/L或下降≥75%可预测自体肝生存≥15年。

核心结论

  • 严重BSEP缺陷的基因型可强烈预测长期自体肝生存、肝细胞癌发生风险及手术胆汁分流增加自体肝生存的机会。
  • 手术胆汁分流后早期血清胆汁酸参数可预测长期自体肝生存。

研究设计与样本

  • 多中心、回顾性队列研究,纳入264例携带纯合或复合杂合致病性ABCB11突变的患者。
  • 按基因型严重程度分为BSEP1、BSEP2、BSEP3三组,预测残余BSEP转运功能逐级降低。

主要发现

  • 基因型严重程度与自体肝生存期显著相关:BSEP1中位20.4年,BSEP2为7.0年,BSEP3为3.5年(p<0.001)。
  • 15岁时肝细胞癌比例:BSEP1为4%,BSEP2为7%,BSEP3为34%(p=0.001)。
  • 在BSEP1和BSEP2中,手术胆汁分流与自体肝生存显著增加相关(风险比0.50;95%CI 0.27-0.94;p=0.03)。
  • 术后早期血清胆汁酸浓度低于102 μmol/L或下降至少75%,均可可靠预测手术后自体肝生存≥15年(各p<0.001)。

关键数值与推荐

  • 基因型严重程度分类:BSEP1、BSEP2、BSEP3,预测残余BSEP转运功能逐级降低。
  • 自体肝生存期中位数:BSEP1为20.4年,BSEP2为7.0年,BSEP3为3.5年(p<0.001)。
  • 15岁时肝细胞癌比例:BSEP1为4%,BSEP2为7%,BSEP3为34%(p=0.001)。
  • 手术胆汁分流与自体肝生存增加相关:风险比0.50(95%CI 0.27-0.94;p=0.03),见于BSEP1和BSEP2。
  • 术后早期血清胆汁酸<102 μmol/L或下降≥75%预测自体肝生存≥15年(各p<0.001)。

临床怎么用

  • 基因型数据可用于指导严重BSEP缺陷患者从儿童期至成年期的个体化临床管理。
  • 术后早期血清胆汁酸参数可用于评估手术胆汁分流的长期自体肝生存前景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Mutations in ABCB11 can cause deficiency of the bile salt export pump (BSEP), leading to cholestasis and end-stage liver disease. Owing to the rarity of the disease, the associations between genotype and natural history, or outcomes following surgical biliary diversion (SBD), remain elusive. We aimed to determine these associations by assembling the largest genetically defined cohort of patients with severe BSEP deficiency to date. METHODS: This multicentre, retrospective cohort study included 264 patients with homozygous or compound heterozygous pathological ABCB11 mutations. Patients were categorized according to genotypic severity (BSEP1, BSEP2, BSEP3). The predicted residual BSEP transport function decreased with each category. RESULTS: Genotype severity was strongly associated with native liver survival (NLS, BSEP1 median 20.4 years; BSEP2, 7.0 years; BSEP3, 3.5 years; p <0.001). At 15 years of age, the proportion of patients with hepatocellular carcinoma was 4% in BSEP1, 7% in BSEP2 and 34% in BSEP3 (p = 0.001). SBD was associated with significantly increased NLS (hazard ratio 0.50; 95% CI 0.27-0.94: p = 0.03) in BSEP1 and BSEP2. A serum bile acid concentration below 102 μmol/L or a decrease of at least 75%, each shortly after SBD, reliably predicted NLS of ≥15 years following SBD (each p <0.001). CONCLUSIONS: The genotype of severe BSEP deficiency strongly predicts long-term NLS, the risk of developing hepatocellular carcinoma, and the chance that SBD will increase NLS. Serum bile acid parameters shortly after SBD can predict long-term NLS. LAY SUMMARY: This study presents data from the largest genetically defined cohort of patients with severe bile salt export pump deficiency to date. The genotype of patients with severe bile salt export pump deficiency is associated with clinical outcomes and the success of therapeutic interventions. Therefore, genotypic data should be used to guide personalized clinical care throughout childhood and adulthood in patients with this disease.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. van Wessel DBE, Thompson RJ, Gonzales E, et al. Genotype correlates with the natural history of severe bile salt export pump deficiency. J Hepatol. 2020. PMID: 32087350. doi:10.1016/j.jhep.2020.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。